As the pioneers of Click-to-Release technology, we use in vivo click chemistry to increase efficacy & decrease toxicity across several systemic treatment modalities.


Team works

We are led by a seasoned team of researchers, oncologists, and biotech business builders, all motivated by a desire to bring safe, effective treatments to patients.


Click-to-Release Technology

We have built a leading technology that enables controlled drug release induced by an in vivo click reaction with a trigger molecule with the aim to increase the therapeutic window and utility of potent systemic therapies. Key applications include the on-target activation of antibody-drug conjugates (ADCs) and immunomodulators in the tumor microenvironment, as well as the off-target deactivation of unwanted circulating radiopharmaceuticals.


Expanding the Therapeutic Potential of ADCs

Conventional ADCs are limited to suitable internalizing targets, which are not necessarily expressed by every cancer type and cancer cell. We are leveraging our Click-to-Release approach to expand the ADC target scope to non- or poorly internalizing receptors and markers. It also enables controlled drug release with a broad bystander effect that makes it possible to kill tumors with heterogenous target expression. Our lead program, TGW101, is a click-cleavable ADC targeting TAG72, a clinically validated non-internalizing target that is widely expressed in solid tumors, but which has so far remained out of reach of current ADC therapies.



April 23, 2024
Marc Robillard will present Tagworks at the 24th BioEquity Europe on May 14 at 11:30 in San Sebastián, Spain.
February 27, 2024
We are pleased to announce the recent appointments of Maria V. Cincotta as our VP of Clinical Operations & Program Management and Tu-Anh T. Bui as our VP of CMC …
February 20, 2024
The 17th Annual European Life Sciences CEO Forum will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of …

Curious about what we do? Get in touch!


About    Our Technology   Pipeline    Join us    News    Contact

T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra